webinar register page

Webinar banner
Evolving therapies to treat chronic kidney disease: SGLT2 inhibitors, MRAs and beyond
1. Describe the unmet need and residual risk of progression in CKD
2. Review benefits of SGLT2 inhibitors in CKD
3. Role of novel MRA treatment for CKD
4. Understand potential role for emerging therapies for CKD

Oct 28, 2022 07:30 AM in Pacific Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: BC Renal.